Watts Water elects Rebecca Boll to board; two directors not standing for re-election

WATTS WATER TECHNOLOGIES INC

Rebecca Boll elected director effective Feb 7, 2024; serves on Governance/Sustainability and Audit Committees.
Christopher L. Conway will not stand for re-election at May 22, 2024 annual meeting (personal reasons; no dispute).
W. Craig Kissel also not standing for re-election due to mandatory retirement age (72) under corporate governance guidelines.
Boll receives 326 shares of class A common stock under the 2004 Stock Incentive Plan plus pro-rata cash retainer.

item 1.01 item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Rebecca Boll

Director

WTS · WATTS WATER TECHNOLOGIES INC

Effective: 2024-02-07
Filed: February 9, 2024, 6:59 PM ET

On February 7, 2024, the Board of Directors of the Registrant elected Rebecca Boll to serve as a member of the Registrant’s Board of Directors until the Registrant’s 2024 Annual Meeting of Stockholders or until her successor has been duly elected and qualified.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Rebecca Boll was elected as Director at WATTS WATER TECHNOLOGIES INC.

Action: elected
Role: Director

Exact text from the filing

On February 7, 2024, the Board of Directors of the Registrant elected Rebecca Boll to serve as a member of the Registrant’s Board of Directors until the Registrant’s 2024 Annual Meeting of Stockholders or until her successor has been duly elected and qualified.

View on SEC.gov

WATTS WATER TECHNOLOGIES INC filing history →

Source: SEC EDGAR

accession 0001558370-24-000927

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.